论文信息 - Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies - 字舞流文

Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies

P. Machado | A. Deodhar | L. Gensler | H. Marzo-Ortega | F. E. Van den Bosch | X. Baraliakos | B. Sherif | E. Quebe-Fehling | B. Porter | C. Gaillez | E. Quebe‐Fehling